JY
ERAS icon

Jeff Yass’s Erasca ERAS Stock Holding History

Jeff Yass’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$427K Sell
23,298
-130,349
-85% -$1.86M ﹤0.01% 10261
2026
Q1 		$2.49M Sell
153,647
-46,141
-23% -$545K ﹤0.01% 5664
2025
Q4 		$743K Buy
199,788
+92,546
+86% +$260K ﹤0.01% 7886
2025
Q3 		$234K Sell
107,242
-201,395
-65% -$320K ﹤0.01% 10646
2025
Q2 		$392K Buy
308,637
+71,687
+30% +$96K ﹤0.01% 9737
2025
Q1 		$325K Buy
236,950
+121,449
+105% +$208K ﹤0.01% 9898
2024
Q4 		$290K Buy
115,501
+56,002
+94% +$154K ﹤0.01% 9909
2024
Q3 		$162K Buy
59,499
+9,960
+20% +$28.1K ﹤0.01% 10664
2024
Q2 		$117K Sell
49,539
-10,967
-18% -$23.7K ﹤0.01% 10903
2024
Q1 		$125K Sell
60,506
-1,248
-2% -$2.49K ﹤0.01% 11065
2023
Q4 		$132K Sell
61,754
-71,215
-54% -$150K ﹤0.01% 11090
2023
Q3 		$262K Sell
132,969
-34,025
-20% -$87.2K ﹤0.01% 9653
2023
Q2 		$461K Sell
166,994
-196,376
-54% -$559K ﹤0.01% 8513
2023
Q1 		$1.09M Buy
363,370
+337,893
+1,326% +$1.23M ﹤0.01% 6570
2022
Q4 		$110K Sell
25,477
-16,991
-40% -$115K ﹤0.01% 10875
2022
Q3 		$331K Buy
+42,468
New +$342K ﹤0.01% 9534
2022
Q2 		– Sell
-30,486
Closed -$262K – 13143
2022
Q1 		$262K Buy
+30,486
New +$353K ﹤0.01% 10589

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jeff Yass's ERAS Position: Q2 2026 in Review

Jeff Yass reduced its Erasca (ERAS) stake by 85% in Q2 2026, selling an estimated $1.86M and leaving 23,298 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #10261.

Jeff Yass first reported a position in ERAS in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.49M in Q1 2026. 255 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Jeff Yass held 23,298 shares of Erasca worth $427K as of Q2 2026.
  • Jeff Yass sold 130,349 Erasca shares in Q2 2026, an estimated $1.86M.
  • Erasca made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10261 holding.
  • Jeff Yass first reported a position in Erasca in Q1 2022 and has held it in 17 quarters since.
  • Jeff Yass's Erasca position peaked at $2.49M in Q1 2026.
  • 255 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.